Efficacy Study of Targeted, Local Delivery of Drugs to Treat Crohn's Disease

NCT00287170 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Crohn's Disease

Interventions

DRUG: Delayed Release 6MP or Calcitriol vs. Purinethol

Sponsor

Teva GTC